5367 |
My Clinical Experiences of Evolocumab in ACS Patients |
Wonjae Lee |
Nov. 10. 21 |
5366 |
'Higher Risk, Higher Benefit' Strategy with Evolocumab in Post-MI Patients |
Youngwoo Jang |
Nov. 10. 21 |
5365 |
LDL-C Lowering Strategies for ACS Patients: How Early is Early? |
Yong-Hoon Yoon |
Nov. 10. 21 |
5364 |
New Concept for CTO Guidewire Manipulation Importance of Penetration Plane View(PPV) |
Kenya Nasu |
Nov. 10. 21 |
5363 |
Updated Techniques and Concepts 2021 for Complex Bifurcation PCI |
Shaoliang Chen |
Nov. 10. 21 |
5362 |
Updated Imaging-Guided ISR PCI 2021 |
Do-Yoon Kang |
Nov. 10. 21 |
5361 |
Updated Imaging/Physiology-Guided PCI Tuning 2021 |
Jung-Min Ahn |
Nov. 10. 21 |
5360 |
Updated Techniques and Concepts 2021 for Complex Left Main PCI |
Seung-Jung Park |
Nov. 10. 21 |
5359 |
Action Plan: Minimizing contrast-induced nephropathy in CTO PCI |
Hirokazu Konishi |
Nov. 10. 21 |
5358 |
Action Plan: Contrast Does Not Flow After Stenting |
Toru Naganuma |
Nov. 10. 21 |